COMMUNIQUÉS West-GlobeNewswire

AB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CET
01/03/2024
PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON MONDAY MARCH 4, 2024 FROM 6.30PM TO 7.30PM CET Paris, 1 March, 2024, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) will host a live webcast on Monday March 4, [...]
AB Science tiendra une conférence virtuelle le lundi 4 mars 2024, de 18h30 à 19h30
01/03/2024
COMMUNIQUE DE PRESSE AB SCIENCE TIENDRA UNE CONFERENCE VIRTUELLE LE LUNDI 4 MARS 2024, DE 18H30 A 19H30 Paris, 1er mars 2024, 18h AB Science SA (Euronext – FR0010557264 – AB) tiendra une conférence virtuelle le lundi 4 [...]
Orion Corporation: Transfer of 150,118 own B shares on 1 March 2024
01/03/2024
ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES IN COMPANY’S OWN SHARES 1 MARCH 2024 at 18.50 EET Orion Corporation: Transfer of 150,118 own B shares on 1 March 2024 In accordance with a decision by the Board of [...]
Number of voting rights as of February 29, 2024
01/03/2024
Nicox SA Société anonyme with a registered capital of € 50,299,694 Head Office: Sundesk Sophia Antipolis, Emerald Square, rue Evariste Galois – 06410 Biot R.C.S. ANTIBES 403.942.642 On March 1 st , 2024, MONTHLY [...]
Nombre de droits de vote au 29 février 2024
01/03/2024
Nicox SA Société anonyme au capital de 50 299 694 euros Siège social : Sundesk Sophia Antipolis, Emerald Square, rue Evariste Galois, 06410 Biot R.C.S. ANTIBES 403.942.642 Le 1 er mars 2024, PUBLICATION MENSUELLE DU [...]
Not too late to vaccinate
01/03/2024
Health officials encourage vaccination as respiratory illnesses continue to spread JEFFERSON CITY, Mo., March 01, 2024 (GLOBE NEWSWIRE) -- With respiratory illnesses continuing to spread, the Missouri Department of [...]
Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference
01/03/2024
Press release – No. 3 / 2023 Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference Copenhagen, Denmark, March 1, 2024 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a [...]
Foundation for Sarcoidosis Research Partners to Host 30 Volunteer Patient Leaders at Unique In-Person Training at Cleveland Clinic
01/03/2024
CHICAGO, March 01, 2024 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is honored to host its inaugural in-person training of FSR-GSCA Volunteer Patient Leaders from around the United States at [...]
WW International, Inc. to Present at the Morgan Stanley Technology, Media & Telecom Conference
01/03/2024
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced that it will present at the following investor conference. Morgan Stanley [...]
Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference
01/03/2024
DURHAM, N.C., March 01, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today [...]
Evaxion organisera une journée R&D le 19 mars 2024 lors de laquelle elle mettra en avant ses dernières innovations technologiques
01/03/2024
COPENHAGUE, Danemark, 01 mars 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ : EVAX) (« Evaxion » ou la « Société »), une société de biotechnologie spécialisée dans la recherche clinique et le développement de [...]
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
01/03/2024
Please see enclosed pdf. Attachment 01032024_trading_in_shares_ARA
Chiesi Global Rare Diseases Launches “Rethink Acromegaly” Campaign to Provide Important Disease Education and Support to the Acromegaly Community
01/03/2024
Rethink Acromegaly is created by Chiesi and members of the acromegaly community to help people living with the condition, along with their caregivers and families, to make informed healthcare decisions Program includes [...]
Dyadic to Attend Industry Events in March
01/03/2024
JUPITER, Fla. , March 01, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the [...]
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories
01/03/2024
Kinnate has entered into an Asset Purchase Agreement (the “APA”) with Pierre Fabre Laboratories for global rights to exarafenib and other pan-RAF program assets. The transaction is in furtherance of Kinnate’s previously [...]
SELLAS Life Sciences Delivers Oral Presentation of SLS009 Phase 1 Data for Acute Myeloid Leukemia Patients at 2024 European School of Haematology (ESH) Conference
01/03/2024
- All key study objectives regarding pharmacokinetic, pharmacodynamic, safety, and clinical activity were met - - Complete remission (CR) achieved after three months of treatment with duration of eight months and one [...]
Empowering the Future of Healthcare: How Healthcare Triangle's AI Initiative Sets a New Standard in Patient Care Excellence
01/03/2024
PLEASANTON, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” HCTI” or the “Company”), embarks on a major initiative to integrate Artificial Intelligence (AI) and [...]
Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on March 6, 2024
01/03/2024
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]
Alumis Presents Preclinical Data for Allosteric TYK2 Inhibitor A-005 at ACTRIMS
01/03/2024
– A-005 is a potential first-in-class, brain penetrant TYK2 inhibitor for the treatment of neuroinflammatory and neurodegenerative diseases – – Data support planned Phase 1 clinical trial on track to initiate in 1H 2024 [...]

Pages